- Asthma can be curbed by the use of N95 grade respiratory protective masks.
- People who have difficulty breathing cannot wear a mask, which will have negative impact on the market.
- The N95 mask provides respiratory system protection with by blocking of 95% of very small (0.3 micron) particles.
Growing demand for personal protection safety devices like masks, hand gloves for rising frequencies of infectious diseases like corona virus, plague etc. with the rapid surge in patient pools across the globe are expected to boost the growth of the N95 grade medical protective masks market over forecast period.
The Global N95 Grade Medical Protective Masks Market is valued at $740.24 Million in 2018 and expected to reach $1091.18 Million by 2025 with the CAGR of 5.70% over the forecast period.
Scope of N95 Grade Medical Protective Masks Market
N95 Grade Medical Protective Masks are respiratory protective devices intended to protect the wearer from liquid and airborne particles contaminating the nose and mouth through very efficient filtration of airborne particles. The N95 mask provides respiratory system protection with by blocking of 95% of very small (0.3 micron) particles.
The N95 grade medical mask has received FDA approval in health care settings and can be used by the any individual. An N95 respirator requires a proper fit to the face. It is provided with adjustable straps for a tight and comfortable setting. The clearance of these respirators involves the evaluation of safety data from bio-compatibility testing and performance testing from fluid resistance and flammability testing.
However, the N95 respirator is associated with various test methods, labeling, conditioning requirements, independent processes and quality control audits, followed by inspection programs for the intended use. Most N95 masks are intended for the single-use, to protect patients and healthcare workers, or are used in construction and other industrial situations that expose workers to dust and small particles. Recently the demand for N95 masks has increased tremendously due to rapid increase in infectious diseases such as Corona virus, etc.
The Global N95 Grade medical protective masks market report is segmented on the basis of product type, application, end-user, and by regional & country level. Based on product type, the market is segmented as with exhalation valves, without exhalation valves and others. N95 Grade Medical Protective Masks market is classified on the basis of application are hospital & clinic, personal care/individual, industrial and others.
The regions covered in this N95 Grade medical protective masks market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, market of N95 Grade medical protective masks is sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.
Global N95 Grade medical protective masks market report covers prominent players like 3M, Hakugen, Ansell, Sinotextiles, Shanghai Dasheng, Te Yin, Gerson, Honeywell, Vogmask, Kimberly-Clark, Cardinal Health, KOWA, DACH, CM and others.
- Buy Research Report: UK In Vitro Fertilization (IVF) Market size Surge at a Robust Pace in Terms of Revenue over COVID-19 2026
- Buy Research Report: Combine Harvesters Market to Ride Wave of Profitability on Back of its Versatile Operations
- Buy Research Report: CMP Slurry Market to Grow Two-fold, as Novel CMP Slurries Expand Revenue Pool of Manufacturers
- Buy Research Report: Soil Compaction Machines to Witness Heightened Demand, Underpinned by Array of Infrastructural Initiatives by Government
- Buy Research Report: Luxury Eyewear Sales to Surpass US$ 50 Bn Mark by 2027; Eyeglasses Hold over 60% Market Share
Growing demand of personal protective safety equipment due to rising air pollution, which causes respiratory diseases is expected to grow the N95 grade medical protective masks market. According to WHO, air pollution causes death of around seven million people around the globe annually due to breathing contaminated air containing high levels of pollutants, causing respiratory disorders.
Respiratory diseases impose an immense worldwide health burden. Around 334 million people suffer from asthma which is the most common chronic disease of childhood, affecting 14% of children globally. This can be curbed by the use of N95 grade respiratory protective masks. In addition to this, the aging and geriatric population, with increasing health awareness, is responsible for the growth of protective masks to avoid viral infections.
According to the UN department of economic and social affairs, by 2050 the urban population of developing countries will reach 5.3 billion, with Asia expected to host 63% (approximately 3.3 billion people) and Africa nearly 20% of the world’s urban population. Due to increasing geriatric population, the possibility of viral infection may rise which leads to an increase the demand for N95 grade medical protective masks.
However, the N95 protective respirator mask may not provide full protection through the hazardous infections and it is avoided to use for people with chronic respiratory, cardiac, or other medical conditions that make breathing difficult for a mask wearer to breathe. This situation may hamper market growth to some extent.
North America is dominating the N95 grade medical protective masks market with the potential rate due to a rising hospitalized patient pool of various infectious diseases which requires advanced treatment for healthcare. The US Center for Disease Control and Prevention has detected nearly 1.7 million hospitalized patients annually which acquire Healthcare-associated infections (HCAIs) while being treated for other health issues out of which that more than 98,000 patients die due to these infections. The growth of this market in this region is primarily driven by the increasing patient pool due to an unhealthy diet and sedated lifestyle.
The Asia Pacific and the Middle East is expected to emerge as the fastest-growing regional market due to rapidly increasing demand of N95 protective masks to the huge patient pool of severe infectious diseases like corona virus. The growing need for protective masks to the patient as well as individuals trying to avoid becoming patients due to outbreaks of infectious diseases like corona virus has substantially increased the demand of N95 respiratory protective masks in the global market.
According to the World Economic Forum in 2020, there have been more than 81000 confirmed cases of corona virus infection (COVID-19), which has emerged in more than 24 countries with more than 2700 deaths around the world.
Europe is the third-largest region dominating the growth of N95 protective respiratory mask due to rise of infectious and non-communicable Diseases (NCDs) like, cardiovascular diseases, influenza viral infection. According to WHO, the Europe region accounts to rise of NCDs with around 77% of the disease burden which directly increases the demand for N95 grade medical protective masks for people with weakened immune systems to avoid viral infections.